Menu

Zimmer Biomet Holdings, Inc. ZBH

Full chart Compare
Set alert

Price alert · ZBH

All alert types
108.03 USD -0.30 (-0.28%)

Nov 10, 2026, 10:33 AM EST

107.53 Day range 108.78
79.58 52-week range 110.15
YTD
+20.14%
1 year
+21.75%
Market cap
20.44B
Revenue (ttm)
8.57B
Profit margin
8.95%
EPS (ttm)
3.96
Shares out
189.25M
P/E ratio
27.28
Forward P/E
12.07
Dividend
0.96 (0.99%)
Ex-dividend date
Sep 29, 2026
YTD return
+20.14%
1-year return
+21.75%
Volume
239.15K
Avg volume
2.09M
Open
108.78
Previous close
108.33
Day's range
107.53 – 108.78
52-week range
79.58 – 110.15
Beta
0.47
Analysts
Hold
Price target
116.24 (+7.6%)
Earnings date
Feb 9, 2027

5D -2.80 (-2.53%)

105107.50110112.50WedThuFriMonTue107.95

Key statistics

Enterprise value
27.22B
PEG ratio
0.66
Price / sales
2.39
Price / book
1.62
Dividend yield
0.91%
Payout ratio
24.24%
Revenue growth
3.10%
Free cash flow
1.44B
Total cash
426.90M
Total debt
7.66B
Return on equity
6.03%
Short % of float
5.53%
50-day average
95.12
200-day average
92.03

Financials — quick view

All financials
ZBH Revenue — quarterly 2.06B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ZBH Net income — quarterly 191.60M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ZBH EPS — quarterly 1.01
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

ZBH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 9, 2027Dec 30, 20262.49———
Nov 4, 2026Sep 30, 20261.881.90+0.02+1.06%
Aug 5, 2026Jun 30, 20262.012.07+0.06+2.99%
Apr 28, 2026Mar 31, 20261.862.09+0.23+12.37%
Feb 10, 2026Dec 31, 20252.382.42+0.04+1.68%
Nov 5, 2025Sep 30, 20251.871.90+0.03+1.60%

Upgrades / downgrades

ZBH analyst upgrades and downgrades
DateFirmActionFromTo
Nov 9, 2026BarclaysmainEqual-WeightEqual-Weight
Nov 5, 2026UBSmainBuyBuy
Nov 5, 2026JP MorganmainNeutralNeutral
Nov 5, 2026CitigroupmainNeutralNeutral
Nov 5, 2026RBC CapitalmainOutperformOutperform
Nov 5, 2026BernsteinmainMarket PerformMarket Perform

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on ZBH — it syncs with the Stock Master app.

Insider holders

ZBH insider holders
InsiderRelationLatest transactionDateShares held
BEZJAK MARKOfficerConversion of Exercise of derivative securityMar 5, 202513,134
ELLINGSON RACHEL H.OfficerConversion of Exercise of derivative securityFeb 19, 202511,906
NOOR JEHANZEBOfficerConversion of Exercise of derivative securityMar 31, 20265,151
PHIPPS CHAD FOfficerSaleSep 3, 202665,231
STELLATO PAUL AOfficerConversion of Exercise of derivative securityMar 5, 20265,582
TORNOS IVANChief Executive OfficerConversion of Exercise of derivative securityMar 5, 202683,191

Institution ownership

ZBH institution ownership
Holder% heldSharesValueReported
Dodge & Cox Inc.12.65%24,124,7352.61BJun 29, 2026
Blackrock Inc.8.19%15,614,8471.69BJun 29, 2026
Harris Associates L.P.6.68%12,738,0251.38BJun 29, 2026
Vanguard Capital Management LLC6.62%12,634,9371.37BJun 29, 2026
Capital International Investors6.39%12,183,6141.32BJun 29, 2026
State Street Corporation4.65%8,877,171962.02MJun 29, 2026

Fund ownership

ZBH fund ownership
Holder% heldSharesValueReported
Dodge & Cox Funds-Dodge & Cox Stock Fund8.15%15,549,9001.69BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.22%6,141,461665.55MJun 29, 2026
VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund3.08%5,867,350635.84MJul 30, 2026
HARRIS ASSOCIATES INVESTMENT TRUST-Oakmark Fund2.95%5,621,292609.18MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.63%5,010,793543.02MJun 29, 2026
WASHINGTON MUTUAL INVESTORS FUND2.42%4,610,277499.62MSep 29, 2026